Alkem Laboratories vs Torrent Pharmaceuticals vs Mankind Pharma: Which Stock Should You Track
- September 23, 2026
- Posted by: Harsh Piplani
- Category: Market
Alkem Laboratories PE 28.95, mkt cap Rs 63,814 crore. Torrent Pharmaceuticals PE 88.06, mkt cap Rs 1,89,842 crore. Mankind Pharma PE 49.53, mkt cap Rs 1,02,410 crore.
Quick Answer
Alkem Laboratories vs Torrent Pharmaceuticals vs Mankind Pharma is a side-by-side comparison of three companies from the Domestic Formulations Pharma space. On this comparison, Alkem Laboratories carries a market capitalisation of about Rs 63,814 crore against Rs 1,89,842 crore for Torrent Pharmaceuticals and Rs 1,02,410 crore for Mankind Pharma, with return on equity of 16.66%, 25.49% and 11.74% respectively. Each company’s numbers are presented here without a declared better pick, since the right stock depends on an investor’s own criteria.
Alkem Laboratories vs Torrent Pharmaceuticals vs Mankind Pharma starts with the core numbers most investors compare within the Domestic Formulations Pharma segment: market capitalisation, valuation multiples, profitability and dividend yield. Figures below are sourced as of September 2026 and will shift with daily price moves.
All three names sit in the Domestic Formulations Pharma bucket, which makes them a natural set to place side by side rather than a random trio of unrelated businesses.
Click Here – Get Free Investment Predictions
Alkem Laboratories, Torrent Pharmaceuticals and Mankind Pharma: Company Overview
Alkem Laboratories is a listed Indian company in the Domestic Formulations Pharma space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.
Torrent Pharmaceuticals is a listed Indian company in the Domestic Formulations Pharma space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.
Mankind Pharma is a listed Indian company in the Domestic Formulations Pharma space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.
Alkem Laboratories vs Torrent Pharmaceuticals vs Mankind Pharma: Valuation and Profitability Snapshot
| Metric | Alkem Laboratories | Torrent Pharmaceuticals | Mankind Pharma |
|---|---|---|---|
| Market Cap (approx.) | Rs 63,814 crore | Rs 1,89,842 crore | Rs 1,02,410 crore |
| PE Ratio (TTM) | 28.95 | 88.06 | 49.53 |
| PB Ratio | 4.62 | 22.57 | 6.28 |
| Return on Equity (ROE) | 16.66% | 25.49% | 11.74% |
| EPS (TTM, Rs) | 184.35 | 56.68 | 50.06 |
| Dividend Yield | 0.99% | 0.68% | 0.04% |
| Debt to Equity | 0.15 | 1.79 | 0.39 |
| Book Value per Share (Rs) | 1155.87 | 221.09 | 394.64 |
Check the Univest Screener for Live Data
On valuation, Alkem Laboratories trades at a PE of 28.95 and a PB of 4.62, Torrent Pharmaceuticals at a PE of 88.06 and a PB of 22.57, while Mankind Pharma trades at a PE of 49.53 and a PB of 6.28. On return on equity, the three post 16.66%, 25.49% and 11.74% respectively, and on dividend yield they stand at 0.99%, 0.68% and 0.04%.
Alkem Laboratories vs Torrent Pharmaceuticals vs Mankind Pharma: Latest Quarterly Results
| Company | Latest Quarter Revenue | Latest Quarter Net Profit | YoY Change (Revenue) | QoQ Change (Revenue) |
|---|---|---|---|---|
| Alkem Laboratories | Rs 3,892.90 crore | Rs 521.49 crore | +11.0% | +2.4% |
| Torrent Pharmaceuticals | Rs 4,909.00 crore | Rs 566.00 crore | +56.3% | +17.4% |
| Mankind Pharma | Rs 4,075.59 crore | Rs 574.09 crore | +11.7% | +14.6% |
Quarterly figures above are the most recent reported quarter for each company (Q1 FY28, quarter ended June 2026), compared with the year-ago and preceding quarter.
Download the Univest iOS App or Univest Android App to track Alkem Laboratories, Torrent Pharmaceuticals and Mankind Pharma live prices.
What Should Investors Look at Beyond These Numbers?
Beyond the metrics above, investors comparing these three domestic formulations pharma names should track quarter-on-quarter revenue and margin trends, management commentary on demand and cost drivers, and any sector-specific regulatory developments, since a single-quarter snapshot can shift quickly.
Conclusion
Alkem Laboratories vs Torrent Pharmaceuticals vs Mankind Pharma highlights how differently three companies in the same domestic formulations pharma segment can score across valuation, profitability and dividend metrics, even when operating in a similar space. This comparison does not declare a winner; investors should weigh these figures against their own research and risk appetite. Please read the disclaimer below before making any investment decision.
Disclaimer: Data and figures in this article are sourced from publicly available information as of September 2026 and may not reflect real-time prices. Please verify all data independently before making any investment decision. This comparison does not recommend or endorse any single stock over another; investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Alkem Laboratories vs Torrent Pharmaceuticals vs Mankind Pharma
What is the market cap difference between Alkem Laboratories, Torrent Pharmaceuticals and Mankind Pharma?
Ans. As of September 2026, Alkem Laboratories has a market cap of approximately Rs 63,814 crore, Torrent Pharmaceuticals is at approximately Rs 1,89,842 crore, and Mankind Pharma is at approximately Rs 1,02,410 crore.
Which of the three has the highest PE ratio?
Ans. Among Alkem Laboratories, Torrent Pharmaceuticals and Mankind Pharma, the PE ratios stand at 28.95, 88.06 and 49.53 respectively as of September 2026.
Which of the three has the highest ROE?
Ans. Alkem Laboratories, Torrent Pharmaceuticals and Mankind Pharma post ROE of 16.66%, 25.49% and 11.74% respectively as of September 2026.
Which of these three stocks pays the highest dividend yield?
Ans. Alkem Laboratories, Torrent Pharmaceuticals and Mankind Pharma carry dividend yields of 0.99%, 0.68% and 0.04% respectively.
What is the debt to equity ratio for Alkem Laboratories, Torrent Pharmaceuticals and Mankind Pharma?
Ans. Alkem Laboratories carries a debt to equity of 0.15, Torrent Pharmaceuticals of 1.79, and Mankind Pharma of 0.39.
Which of the three trades at the highest price to book value?
Ans. Alkem Laboratories, Torrent Pharmaceuticals and Mankind Pharma trade at price to book ratios of 4.62, 22.57 and 6.28 respectively.
Is one of Alkem Laboratories, Torrent Pharmaceuticals or Mankind Pharma better than the others?
Ans. This comparison does not declare one stock better than another; each company scores differently across valuation, profitability and dividend metrics, and the right fit depends on an individual investor’s own criteria and research.
